S. KOREAN STOCKS END LOW ON THURSDAY; KOSPI FELL

Highlights –

• S. Korean stocks end low on Thursday; KOSPI fell.
• KOSPI fell 7.4 points, or 0.23 percent, to close at 3,174.07 points.
• Samsung Electronics stocks lost 0.49 percent to 81,700 won.
• SK hynix stocks closed unchange...

S. KOREAN STOCK END LOW OVER RISING VALUATION PRESSURE

Highlights –

• S. Korean stock end low over rising valuation pressure.
• The KOSPI fell 1.38 points, or 0.36 percent,.
• Samsung Electronics stocks lost 1.3 percent to 83,600 won.
• SK Hynix stocks fell 2.78 percent to 140,000 won....

CELLTRION WILL SUPPLY ITS COVID-19 TREATMENT WITHOUT PROFIT MARGIN IN S. KOREA

Highlights –

• Celltrion will supply its COVID-19 treatment without profit margin in S. Korea.
• Celltrion’s CT-P59 began to be supplied to local medical institutions on Wednesday.
• The company has also planned to supply the treatmen...

CELLTRION’S COVID-19 ANTIBODY TREATMENT CONFIRMED TO NEUTRALIZE VIRUS VARIANT

Highlights –

• Celltrion’s COVID-19 antibody treatment confirmed to neutralize virus variant.
• The company’s CT-P59, an anti-COVID-19 monoclonal antibody treatment neutralized the British virus variant.
• The company has also t...

S. KOREA APPROVES CELLTRION INC.’S COVID-19 ANTIBODY TREATMENT WITH CONDITIONS

Highlights –

• S. Korea approves Celltrion Inc.’s COVID-19 antibody treatment with conditions.
• The country’s drug safety agency has given conditional marketing authorization of CT-P59.
• Celltrion plans to conduct a global pha...

S. KOREAN STOCKS OVER FOREIGN AND INSTITUTIONAL BUYING CLOSED HIGH ON MONDAY

Highlights –

• S. Korean stocks over foreign and institutional buying closed high on Monday.
• KRX reported the KOSPI jumped 80.32 points, or. 2.7 percent.
• Samsung Electronics added 1.22 percent to 83,000 won.
• SK Hynix Inc. sto...

SOUTH KOREA’S OWN COVID-19 VACCINE TO BE DEVELOPED LATE NEXT YEAR

Highlights –

• South Korea’s own COVID-19 vaccine to be developed late next year.
• South Korean Prime Minister announced the same on Thursday.
• Whereas foreign vaccines are scheduled to be administered starting early next year.
...

S. KOREA GOVERNMENT TO INVEST $470 BILLION IN BIOTECHNOLOGY IN FISCAL 2021

Highlights –

• S. Korea government to invest $470 billion in biotechnology in fiscal 2021.
• The country’s Ministry of Science and ICT represents a 24.9% hike from 2020.
• Until 2030 the government plans to spend a total of 2.2 trilli...

SARTORIUS TO PLOUGH $100 MILLION IN SONGDO BIOCLUSTER

• Sartorius, a German life sciences company with 170 years of background history, announced Thursday it will pour funds to the tune of $100 million in South Korea’s bio cluster of Songdo in Incheon to build a manufacturing facility for biologics plant parts.
• Sartorius&rsquo...

Korean biopharmaceuticals expands its global presence

 Based on a report, local pharmaceutical companies in South Korea are shifting their gaze to overseas markets. Reports allege 209 pharmaceutical companies have extended their businesses in 2018, these include establishing plants or subsidiaries, the number increased four times from 2016. Sou...